Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

461
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
461
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

48
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
48
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
Ligand Binding Sites02:40

Ligand Binding Sites

12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

509
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
509

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigation.

Cancer chemotherapy and pharmacology·2026
Same author

Quantitative Systems Pharmacology Modeling Amid the Rise of Agentic AI.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Follow-Up Bias in Tumor Dynamic Modeling: A Comparison of Classical and Neural-ODE Approaches.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Integrating Patient Engagement into Clinical Pharmacology and Pharmacometrics: Bringing the Patient Voice into Data-Driven Science.

Clinical pharmacology and therapeutics·2026
Same author

A phase 1 study of the breast milk and plasma pharmacokinetics of zavegepant 10 mg intranasal dose in healthy lactating women.

Headache·2026
Same author

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development.

Clinical pharmacology and therapeutics·2025

Related Experiment Video

Updated: May 15, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

466

Large Language Models and Their Applications in Drug Discovery and Development: A Primer.

James Lu1, Keunwoo Choi2, Maksim Eremeev2

  • 1Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.

Clinical and Translational Science
|April 10, 2025
PubMed
Summary
This summary is machine-generated.

Large language models (LLMs) offer powerful applications in clinical pharmacology and translational medicine, enhancing drug discovery, development, and research workflows for scientists.

Keywords:
artificial intelligenceclinical pharmacologydrug developmentdrug discoverylarge language modeltranslational science

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Related Experiment Videos

Last Updated: May 15, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

466
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Area of Science:

  • Pharmacology
  • Translational Medicine
  • Artificial Intelligence

Background:

  • Large language models (LLMs) are increasingly influential across scientific domains.
  • Their potential in specialized fields like clinical pharmacology and translational medicine is significant but requires focused exploration.
  • Understanding LLM capabilities is crucial for advancing drug discovery and development.

Purpose of the Study:

  • To provide a comprehensive primer on the applications of LLMs in clinical pharmacology and translational medicine.
  • To elucidate the fundamental concepts underpinning LLMs relevant to these scientific disciplines.
  • To guide researchers on leveraging LLMs for enhanced research and development efforts.

Main Methods:

  • Exploration of LLM fundamental concepts.
  • Review of potential applications across the drug discovery and development pipeline.
  • Identification of practical use cases in medical writing and quantitative analysis.

Main Results:

  • LLMs can facilitate target identification and aid preclinical research.
  • LLMs assist in clinical trial analysis and quantitative clinical pharmacology workflows.
  • LLMs support medical writing tasks, accelerating analytical processes.

Conclusions:

  • LLMs present transformative potential for clinical pharmacology and translational medicine.
  • Researchers can utilize LLMs to optimize various stages of drug discovery and development.
  • A clear understanding of LLMs empowers scientists to enhance their R&D endeavors.